General Information of Drug (ID: DM178H9)

Drug Name
Bisacodyl Drug Info
Synonyms
bisacodyl; 603-50-9; Dulcolax; Bicol; Durolax; Brocalax; Stadalax; Sanvacual; Hillcolax; Fenilaxan; Endokolat; Theralax; Dulcolan; Nigalax; Laxorex; Laxadin; Neolax; Laxine; Ivilax; Eulaxan; Ulcolax; Telemin; Laxans; Godalax; Zetrax; Pyrilax; Sk-bisacodyl; Laxanin N; Bisacodylum; Bisacodilo; Deficol; LACO; LA96a; Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester); HalfLytely; Bisacodylum [INN-Latin]; Bisacodilo [INN-Spanish]; (Pyridin-2-ylmethylene)bis(4,1-phenylene) diacetate; Bis(p-acetoxyphenyl)-2-pyridylmethane
Cross-matching ID
PubChem CID
2391
ChEBI ID
CHEMBL942
CAS Number
CAS 603-50-9
TTD Drug ID
D07IEF

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
TGF-beta signaling pathway 2.30 0.00e+0 81/94 (86.17%) ID1;INHBA;ID4;...
Signaling pathways regulating pluripotency of stem cell... 2.08 0.00e+0 110/143 (76.92%) ID1;INHBA;ID4;...
MicroRNAs in cancer 1.88 1.10e-2 146/310 (47.1%) THBS1;MCL1;CDK6;...
Colorectal cancer 1.87 8.26e-3 84/86 (97.67%) AREG;EREG;CTNNB1;...
Breast cancer 1.87 6.61e-3 119/147 (80.95%) CTNNB1;CDK6;ESR1;...
Bladder cancer 1.86 5.51e-3 40/41 (97.56%) CXCL8;THBS1;RASSF1;...
AGE-RAGE signaling pathway in diabetic complications 1.82 1.10e-2 97/100 (97%) CXCL8;FN1;F3;...
Chronic myeloid leukemia 1.79 1.38e-2 72/76 (94.74%) NFKBIA;CDK6;BAX;...
Hippo signaling pathway 1.78 1.35e-2 120/186 (64.52%) AREG;ID1;CTNNB1;...
Endometrial cancer 1.78 1.21e-2 56/58 (96.55%) CTNNB1;BAX;CDKN1A;...
Basal cell carcinoma 1.77 1.20e-2 41/63 (65.08%) CTNNB1;BAX;CDKN1A;...
IL-17 signaling pathway 1.77 1.19e-2 84/94 (89.36%) CXCL8;NFKBIA;FOSB;...
Small cell lung cancer 1.76 1.36e-2 90/92 (97.83%) NFKBIA;CDK6;FN1;...
Wnt signaling pathway 1.74 1.42e-2 124/166 (74.7%) SFRP1;CTNNB1;SFRP4;...
Proteoglycans in cancer 1.74 1.47e-2 172/205 (83.9%) THBS1;CTNNB1;ESR1;...
TNF signaling pathway 1.74 1.58e-2 103/112 (91.96%) NFKBIA;CXCL3;CXCL5;...
Melanoma 1.73 1.68e-2 68/72 (94.44%) CDK6;PDGFD;BAX;...
Gastric cancer 1.72 2.14e-2 122/149 (81.88%) CTNNB1;BAX;CDKN1A;...
ECM-receptor interaction 1.71 2.20e-2 80/88 (90.91%) THBS1;FN1;COL4A2;...
Focal adhesion 1.70 2.20e-2 180/201 (89.55%) THBS1;CTNNB1;FN1;...
Adherens junction 1.70 2.31e-2 63/71 (88.73%) CTNNB1;SNAI2;CDC42;...
Kaposi sarcoma-associated herpesvirus infection 1.67 3.00e-2 172/193 (89.12%) CXCL8;CTNNB1;NFKBIA;...
Non-small cell lung cancer 1.66 3.16e-2 70/72 (97.22%) CDK6;RASSF1;BAX;...
FoxO signaling pathway 1.64 4.13e-2 118/131 (90.08%) PRMT1;PLK2;CDKN1A;...
Thyroid cancer 1.63 4.45e-2 36/37 (97.3%) CTNNB1;BAX;CDKN1A;...
DNA replication -1.84 2.41e-2 34/36 (94.44%) POLA1;RNASEH2A;POLD3;...
Arachidonic acid metabolism -1.86 2.92e-2 48/61 (78.69%) ALOX15;PTGIS;CYP2C19;...
Fructose and mannose metabolism -1.87 3.50e-2 30/33 (90.91%) PFKFB4;FBP2;MPI;...
Mismatch repair -2.00 8.75e-3 22/23 (95.65%) POLD3;POLD4;POLD2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 0.37uM - 10uM 6H, 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.37uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H